Pin Oak Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Pin Oak Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,903	Closed	-$11K	–	491
2019 Q1	$11K	Hold	2,903	–	–	0.01%	327
2018 Q4	$8K	Hold	2,903	–	–	0.01%	340
2018 Q3	$8K	Hold	2,903	–	–	0.01%	332
2018 Q2	$7K	Hold	2,903	–	–	0.01%	347
2018 Q1	$9K	Hold	2,903	–	–	0.01%	335
2017 Q4	$8K	Buy	+2,903	New	+$8.92K	0.01%	356

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pin Oak Investment Advisors's PDLI Position: Q2 2019 in Review

Pin Oak Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 2,903 shares — an estimated $11K sold.

Pin Oak Investment Advisors first reported a position in PDLI in Q4 2017 and held it in 6 quarters. The position peaked at $11K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

Pin Oak Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
Pin Oak Investment Advisors sold 2,903 PDL BioPharma, Inc. shares in Q2 2019, an estimated $11K.
Pin Oak Investment Advisors first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 6 quarters.
Pin Oak Investment Advisors's PDL BioPharma, Inc. position peaked at $11K in Q1 2019.
148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.